Novartis Venture Fund logo

Novartis Venture Fund

0 followers

About Novartis Venture Fund

The Novartis Venture Fund invests in life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Recent News

Protego Biopharma Lands $130 Million Oversubscribed Series B Financing

Syneron Raises $150m for Macrocyclics, and Other Financings

FoRx Therapeutics Raises USD50M in Series A Financing

EpiBiologics Closes $107M Series B

Protego Biopharma Raises $130M in Series B Financing

Recent Deals

Protego Biopharma Secures $130M Series B Funding

December 1, 2025

Protego Biopharma Secures $130M Series B Funding Led by Novartis Venture Fund

December 8, 2025

EpiBiologics Raises $107M in Series B to Advance Protein-Degrading Cancer Drug

January 8, 2026

FoRx Therapeutics Secures $50M Series A to Advance Precision Cancer Drug

December 18, 2025